Answers are grounded in this paper and cite their sources.
When aptamers first emerged almost two decades ago, most were RNA species that bound and tagged or inhibited simple target ligands. Very soon after, the 'selectionologists' developing aptamer technology quickly realized more potential for the aptamer. In recent years, advances in aptamer techniques have enabled the use of aptamers as small molecule inhibitors, diagnostic tools and even therapeutics. Aptamers are now being employed in novel applications. We review, herein, some of the recent and exciting applications of aptamers in cell-specific recognition and delivery.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: